Clin2
NCT07629609Possibly a fitRecruiting

New PET scan imaging for pancreatic and stomach cancers

Pancreatic Cancer, AdultGastroesophageal Cancer (GC)

Treatments studied

Part of Cancer, Digestive system, Hormones & metabolism clinical trials.

This study tests a new type of PET scan (a detailed imaging test) called [68Ga]Ga-FAPI that may help doctors see cancer better and faster than standard scans. You'll receive this experimental scan to see if it improves cancer detection before surgery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
90 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have suspected pancreatic cancer OR confirmed stomach/esophageal cancer (depending on which group enrolls you)
  • Your cancer appears treatable with surgery based on initial imaging
  • You are able to read and understand Danish and provide informed consent
  • You are not pregnant or breastfeeding
  • You weigh 140 kg (308 lbs) or less

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07630961Recruiting· Phase 1
New PET Imaging Scans for Advanced Solid Tumors

This trial tests two new radioactive imaging scans (called PET scans) designed to better detect certain advanced cancers like pancreatic, lung, breast, colon, or soft-tissue tumors. The goal is to see if these scans help doctors find and track cancer more accurately than standard imaging.

Odense C
NCT07215182Recruiting· Phase 2
New PET scan method for advanced melanoma

This trial tests a new type of PET scan that may find cancer more clearly and quickly than current scans. It's for people with advanced melanoma that has spread and cannot be removed by surgery.

Herlev, Capital Region
NCT05957250Recruiting
PET scan study to better image pancreatic and bile duct cancer

This study uses a special PET scan drug (Ga-FAPI-46) to create clearer pictures of pancreatic and bile duct cancers. It may help doctors decide on the best next steps—especially before surgery—by checking tumor size and looking for spread.

Amsterdam, North Holland
NCT05172310Recruiting· Phase 1
PET scan study using a new tracer for solid tumors

This trial tests a special PET/CT scan using a new tracer (68Ga-FAPI) to help show tumors in the pancreas, bile ducts, stomach, or certain ovarian cancers. It may help doctors better see where cancer is in preparation for surgery or biopsy.

Stockholm
NCT06659705Recruiting· Phase 2
New PET scan for early pancreatic cancer detection

This trial tests a new type of PET scan that uses a special tracer (FAPI) to get clearer images of pancreatic cancer. The goal is to find cancer earlier and better plan surgery or treatment.

Saint-Cloud
NCT07217717Recruiting· Phase 3
New PET scan for pancreatic cancer staging

This study tests a new type of PET scan that uses a radioactive tracer called FAPI-74 to find cancer spread in people with pancreatic cancer. The goal is to see if this scan can help doctors better plan treatment.

Cerritos, California

Hear when a new Pancreatic Cancer, Adult trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.